Alle Fälle anzeigen
ORD 55063/2024
—·EP3977921: ANALYTE SENSOR AND APPARATUS FOR INSERTION OF THE SENSOR
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieVerfahrensführungsanordnungen
- Parteien
- Division
- Nordic-Baltic RD
- Richter
- Stefan Johansson · Presiding Judge
- Kai Härmand · Judge-Rapporteur
- Pierluigi Perrotti · Legally Qualified Judge
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 7. Okt. 2024
Entscheidungen
- 2024-10-07Generic Order
Nordic-Baltic Regional Division (judge-rapporteur Kai Härmand) preliminary/case management order in Abbott Diabetes Care Inc.'s infringement action against Dexcom Inc. and Dexcom International Limited concerning EP 3 977 921 (a continuous glucose monitoring patent). The order addresses multiple pending applications including Abbott's R. 190 application to communicate information (partially dismissed following Paris LD precedent), Abbott's R. 191 application (found admissible but not justified), Abbott's application to change the statement of claim, Dexcom's request for security for legal costs, and sets procedural deadlines and oral hearing preparation steps.
Rechtsfragen:Application to communicate information (R. 191 RoP / Art. 67 UPCA) – admissible but not justifiedR. 190 RoP evidence orderAmendment of statement of claimSecurity for legal costsPending EPO opposition proceedingsProcedural deadlines and oral hearing preparation
Dokumente
- 8AB7F004808A045446F38FDD51B1F8DF_en.pdf2024-10-07EN